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Abstract
Neutrophils have been implicated in both protective and pathological responses following influenza virus infections. We
have used mAb 1A8 (anti-Ly6G) to specifically deplete LyG6
high neutrophils and induce neutropenia in mice infected with
virus strains known to differ in virulence. Mice were also treated with mAb RB6-8C5 (anti-Ly6C/G or anti-Gr-1), a mAb widely
used to investigate the role of neutrophils in mice that has been shown to bind and deplete additional leukocyte subsets.
Using mAb 1A8, we confirm the beneficial role of neutrophils in mice infected with virus strains of intermediate (HKx31;
H3N2) or high (PR8; H1N1) virulence whereas treatment of mice infected with an avirulent strain (BJx109; H3N2) did not
affect disease or virus replication. Treatment of BJx109-infected mice with mAb RB6-8C5 was, however, associated with
significant weight loss and enhanced virus replication indicating that other Gr-1
+ cells, not neutrophils, limit disease severity
during mild influenza infections.
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Introduction
Neutrophils are recruited to the respiratory tract following
influenza virus infections of humans and mice [1] and large
numbers infiltrate the airways following infection of mice with
highly pathogenic viruses such as the reconstructed 1918 H1N1
virus and strains of H5N1 [2,3]. Current evidence suggests that
neutrophils play a protective role following infection of mice with
(i) human virus strains of intermediate virulence [4,5], (ii) the
mouse-adapted A/PR/8/34 strain (PR8, H1N1) [6,7,8], or (iii) a
virulent recombinant influenza virus expressing the hemagglutinin
(HA) and neuraminidase (NA) of a 1918 pandemic H1N1 virus
[3]. However, depletion of neutrophil-attracting chemokine MIP-2
was associated with reduced neutrophil recruitment and a milder
lung pathology following infection of mice with PR8, suggesting
that dysregulated or excessive neutrophil responses in the airways
may contribute to disease during severe influenza infections [9].
Therefore, the specific role of neutrophils during mild and severe
influenza virus infections remains unclear.
Treatment of mice with mAb RB6-8C5 (anti-Ly6C/G or anti-
Gr-1) has been widely used to deplete neutrophils in a range of
murine models of infection and inflammation (reviewed by [10]),
including influenza virus infection [3,4,8]. However, extending the
findings of Daley et al. [11], we have demonstrated that mAb RB6-
8C5 is not highly specific for neutrophils but binds a range of
additional leukocyte populations in the lung of influenza virus-
infected mice, including CD8
+ T cells, macrophages, NK cells and
conventional and plasmacytoid dendritic cells (cDC and pDC,
respectively). Binding of RB6-8C5 to these cells correlated with
expression of Ly6C, not Ly6G [5] making interpretation of studies
using mAb RB6-8C5 to induce neutropenia complicated by the
unwanted depletion of other Gr-1
+ leukocytes. We showed that
mAb 1A8 binds exclusively to Ly6G
high neutrophils in the airways
of influenza virus-infected mice and specific depletion of Ly6G
+
cells with mAb 1A8 lead to exacerbated disease in mice infected
with virus strain HKx31 (H3N2).
In preliminary studies, we observed that virus strains of low
(BJx109, H3N2), intermediate (HKx31, H3N2) or high virulence
(PR8, H1N1) in mice differed markedly in their ability to recruit
neutrophils to the airways. Given that neutrophils have been
implicated in both protective and pathological responses following
influenza virus infections, we investigated the role of neutrophils in
vivo following infection with virus strains known to differ in
virulence in mice. Moreover, given the widespread use of mAb
RB6-8C5 to deplete neutrophils in mice [3,4,11,12,13,14,15], we
compared the effects of treating mice with either mAb 1A8 or
mAb RB6-8C5 to deplete Ly6G
+ cells or Ly6C
+/Ly6C
+ (i.e.
Gr-1
+) cells, respectively.
Results
Influenza virus strains differ in their virulence for mice
HKx31 (H3N2) and BJx109 (H3N2) are high-yielding reassor-
tants of PR8 with A/Aichi/2/68 (H3N2) and A/Beijing/353/89
(H3N2), respectively, and bear H3N2 surface glycoproteins and
internal components derived from PR8. We first compared the
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17618weight loss (Fig. 1A) and viral loads (Fig. 1B) of B6 mice following
intranasal infection with 10
5 PFU of PR8, HKx31 and BJx109.
Mice infected with BJx109 did not lose weight nor did they display
signs of clinical disease at any time during the 10-day monitoring
period. HKx31-infected mice showed transient weight loss over
the first week of infection but recovered thereafter and no animals
succumbed to infection. In contrast, mice infected with PR8 lost
weight rapidly, displayed evidence of severe clinical disease
(huddling, laboured breathing; data not shown) and were
euthanized 4–5 days post-infection. Therefore these virus strains
were classified to be of low (BJx109), intermediate (HKx31) or high
(PR8) virulence in the murine model of influenza infection.
Viral loads in the lungs of mice were determined 5 days after
infection with each of the viruses (Fig. 1B). This time-point was
chosen as it corresponded to the time at which PR8-infected mice
succumbed to disease (Fig. 1A). BJx109 induces mild disease and is
cleared from lungs by day 5 post-infection (Fig. 1B), although high
virus titres can be recovered when components of innate
immunity, such as airway macrophages, are depleted [16]. At
day 5 post-infection, virus titres were markedly higher in the lungs
of HKx31-infected mice and were 10–100-fold higher again in
lungs of PR8-infected mice. Thus, a direct correlation was
observed between virulence for mice and the ability of each virus
strain to replicate in the airways (i.e. PR8.HKx31.BJx109).
Neutrophil recruitment to respiratory tract following
infection of mice with BJx109, HKx31 or PR8
The cellular inflammatory response to influenza virus infection
was assessed in the lung (via analysis of bronchoalveolar lavage
(BAL)) and in the upper respiratory tract (via analysis of
collagenase-treated nasal tissues) at various time-points after
infection with 10
5 PFU of BJx109, HKx31 or PR8. First, viable
counts were performed to determine total cell numbers recovered
from BAL (Fig. 2A, left panel) or nasal tissues (Fig. 2A, right panel)
of uninfected or virus-infected mice. Low numbers of BAL cells
were recovered from BJx109-infected mice at days 1, 3, 5 and 7
post-infection (Fig. 2A, left panels). Infection of mice with an
equivalent dose of HKx31 led to a greater accumulation of cells in
the airways and by day 5 post-infection BAL cell numbers were
,2.5-fold higher than those recovered from BJx109-infected mice.
PR8 infection was associated with the progressive recruitment of
inflammatory cells to the airways, such that by day 5 BAL cell
numbers were ,14-fold and ,6-fold higher than cell numbers
from BJx109- and HKx31-infected mice, respectively.
Cell numbers in the nasal tissues of mice infected with BJx109
peaked at day 3 post-infection (Fig. 2A, right panel), whereas those
from HKx31-infected mice increased progressively from day 1 to
day 7 post-infection. Note that while high total cell numbers were
recovered from the nasal tissues of BJx109-infected mice at days 1
and 3 post-infection (Fig. 2A, right panel), neutrophil numbers
were not significantly different between groups infected with each
virus at these time points (Fig. 2B, right panel). Infection with PR8
induced recruitment of larger numbers of leukocytes to nasal
tissues and by day 5 post-infection, cell numbers were ,2-fold or
,3-fold higher than numbers recovered from BJx109- or HKx31-
infected mice, respectively.
In preliminary experiments, differential staining of cells
recovered from the BAL and nasal tissues of virus-infected mice
indicated that neutrophils were a prominent component of
infiltrates during the early (days 1–3, BJx109 and HKx31) and
later (day 5, PR8) stages of influenza infection (data not shown).
Therefore, flow cytometry was used to quantify neutrophil
numbers in BAL and nasal tissues at various times after infection
with 10
5 PFU of BJx109, HKx31 or PR8 (Fig. 2B). In previous
studies, we have used cell sorting and morphological analysis to
demonstrate that .95% of CD45
+ Gr-1
high cells in BAL were
neutrophils [4,5]. The neutrophil response to BJx109 and HKx31
peaked 1–3 days after infection and numbers were markedly
higher in BAL fluids from HKx31-infected mice at all time-points
tested. The pattern of neutrophil recruitment into the BAL
following inoculation with PR8 (Fig. 2B) was notably different as
neutrophil numbers were low at day 1 post-infection, but increased
progressively through to day 5 post-infection. Thus, during PR8
infection the accumulation of BAL cells, including neutrophils,
correlated with the development of severe disease. Neutrophils
were recruited into the nasal tissues following infection with each
virus strain and peak neutrophil numbers in BJx109-infected mice
were recovered 3 days after infection. In contrast, neutrophil
numbers increased over time following infection with either
HKx31 or PR8 and similar neutrophil numbers were recovered
from nasal tissues 5 days after infection with either virus strain.
In general terms, the pattern of the neutrophil infiltration into
the BAL following infection with BJx109, HKx31 or PR8
Figure 1. Virulence of influenza viruses for C57BL/6 mice. Mice were infected with 10
5 PFU of BJx109, HKx31 or PR8. (A) Weight loss. Mice
were weighed daily and results expressed as mean percent weight change of each group (6 SEM), compared to the weight immediately prior to
infection. (B) Titres of virus in the lungs at day 5 post-infection. Lungs were removed and titres of infectious virus were determined in clarified
homogenates by standard plaque assay. Data represent mean virus titres 6 1 SEM. The detection limit for the assay is indicated by the dotted line.
Data shown are for groups of 5 mice and are representative of 2 or more independent experiments. *=virus titres from PR8-infected mice were
significantly higher than those from HKx31-infected mice (p,0.001, one-way ANOVA).
doi:10.1371/journal.pone.0017618.g001
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KC, MIP-1a and MIP-2 in the airways (Fig. 2C). KC and MIP-2
were detected in BAL fluids from BJx109-infected mice 1 day after
infection and remained low thereafter. HKx31 induced a similar
pattern of chemokines, but with higher levels of MIP-2 and
additional induction of low levels of MIP-1a. PR8 induced
relatively high levels of each of the 3 chemokines, although levels
were quite variable in BAL fluids at each time-point.
Murine neutrophils are not susceptible to infection by
influenza virus
Given the differing patterns of neutrophil recruitment to the
airways following infection with BJx109, HKx31 or PR8 (Fig. 2B),
we next investigated the susceptibility of purified murine
neutrophils to infection by each virus strains in vitro. First, aliquots
of 10
6 purified bone marrow-derived neutrophils or murine airway
epithelial cells (LA-4) were incubated with 10
7 PFU of BJx109,
Figure 2. Neutrophil response in the airways after infection of mice with BJx109, HKx31 or PR8. Groups of 5 mice were infected with 10
5
PFU of each virus via the intranasal route and at the times indicated, mice were killed and lavage performed. Numbers of (A) total BAL and nasal
tissue cells, and (B) total BAL and nasal tissue neutrophils from virus-infected mice. Cell numbers in the BAL fluids from naı ¨ve mice are included for
comparison. Neutrophils were identified by flow cytometry as CD45
+ Gr-1
high cells. A minimum of 50,000 living cells (PI
2) were collected and analyzed
from each mouse. *=BJx109 is significantly reduced compared to HKx31 and PR8;
#=HKx31 is significantly reduced compared to PR8;
x=HKx31 is
significantly reduced compared to BJx109 and PR8 (p,0.05, one-way ANOVA). (C) Levels of KC, MIP-2 and MIP-1a in BAL supernatants at various
times after influenza virus infection. Naı ¨ve (N) animals were included for comparison. Chemokine levels were determined by ELISA and results are
expressed in pg/mL. The detection limit for each ELISA is indicated by the dotted line. ND=not done as all PR8-infected mice were euthanized at day
5 post-infection.
doi:10.1371/journal.pone.0017618.g002
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and following culture for an additional 2 or 24 hrs, supernatants
were collected, clarified and the levels of infectious virus using a
standard plaque assay on MDCK cells. Titres of infectious virus
had increased ,100-fold in supernatants from BJx109-, HKx31-
and PR8-infected LA-4 cells between 2 and 24 hrs post-infection,
consistent with productive infection of epithelial cells (data not
shown). In contrast, titres of infectious virus did not increase
between 2 and 24 hrs in supernatants from virus-exposed
neutrophils, confirming that they do not support productive
infection by BJx109, HKx31or PR8 (data not shown).
Next, we incubated LA-4 cells and purified neutrophils with
10
7 PFU of each virus strain (as described above) and, following
washing, cells were cultured for a further 8 hrs. After this time,
cells were fixed and stained for intracellular expression of newly
synthesized viral NP. Note that cells incubated with UV-treated
BJx109 (to inactivate infectious virus) were included as controls.
LA-4 epithelial cells were infected by each virus strain (Fig. 3Ai),
whereas viral NP was not detected in cells incubated with UV-
inactivated BJx109. In contrast to LA-4 cells, viral NP protein
was not detected following incubation of neutrophils with
BJx109, HKx31 or PR8 (Fig. 3Aii), indicating that murine
neutrophils are not susceptible to infection by BJx109, HKx31 or
PR8 viruses.
To determine if neutrophils were susceptible to virus entry and/
or the early stages of virus replication (via detection of vRNA)
and/or translation (via detection of mRNA), we incubated LA-4
cells or purified neutrophils with influenza viruses (as described
above) and, at 8 hrs post-infection, RNA was extracted and
quantitative RT-PCR performed to determine levels of vRNA and
mRNA for genes encoding PA and M (Fig. 3B). vRNA was not
detected in mock-infected LA-4 cells, but high levels were detected
in LA-4 cells incubated with either BJx109, HKx31 or PR8
(Fig. 3Bi, left panel). In contrast, vRNA was below detection or
present at low levels in murine neutrophils incubated with virus
(Fig. 3Bi, right panel). A similar pattern of viral mRNA expression
was observed with high levels recorded in LA-4 cells incubated
with BJx109, HKx31 or PR8 (Fig. 3Bii, left panel) but very low/
Figure 3. Neutrophils are not susceptible to influenza virus infection. Mature murine neutrophils were purified from the bone marrow as
described in Materials and Methods. Aliquots of 10
6 (i) LA-4 epithelial cells, or (ii) neutrophils were incubated with 10
7 PFU of BJx109, HKx31 or PR8.
Control cells were incubated with BJx109 that had been UV-inactivated to destroy virus infectivity (UV BJx109). After 1 hr, cells were washed and
incubated an additional 8 hrs. (A) Cells were fixed and levels of intracellular viral NP protein determined by flow cytometry. Histograms shown
represent cells incubated with virus (grey) or uninfected control cells (white). A gate was set to include 5% of cells in the uninfected control and the
percentage of cells staining positive for intracellular NP are shown relative to this in each panel. (B) RNA was extracted from cells and levels of (i) vRNA
and (ii) mRNA encoding NP, PA and M genes determined via quantitative RT-PCR. Cells incubated in media alone (mock) were included as a control.
Data is expressed in pg/ml and represent the mean 6 SD of 3 independent experiments.
doi:10.1371/journal.pone.0017618.g003
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Thus, while murine airway epithelial cells support genomic
replication and productive infection by BJx109, HKx31 and
PR8 viruses, murine neutrophils do not.
Effect of treatment with mAb 1A8 or mAb RB6-8C5 on
the virulence of BJx109, HKx31 and PR8 for mice
mAb RB6-8C5 (anti-Ly6C/G or anti-Gr-1) has been used
extensively by researchers to deplete neutrophils from mice
[3,4,11,12,13,14,15], however use of this mAb is complicated by
its ability to bind to (and therefore deplete) additional leukocyte
populations [4,11,17,18,19,20]. We have previously utilized mAb
1A8 (anti-Ly6G) to specifically deplete neutrophils from the
airways following infection of mice with a low dose (10
2 PFU) of
HKx31 [5]. While cell sorting confirmed that Gr-1
high cells may be
classified as neutrophils [5], we demonstrated that a range of
additional leukocyte subsets recovered from the lungs of HKx31-
infected mice, including CD8
+ cells, NK1.1
+ cells, NKT cell,
macrophage, cDC and pDCs, expressed intermediate levels of Gr-
1 and are therefore likely to be depleted following treatment of
mice with anti-Gr-1 antibodies [5]. In contrast, mAb 1A8 bound
exclusively to Ly6G
high neutrophils in the airways of virus-infected
mice. Moreover, BJx109, HKx31 and PR8 showed marked
differences in their ability to induce leukocytes, including NK cells
and CD8 T cells [21] to the airways, further complicating the use
of mAb RB6-8C5 to compare the role of neutrophils following
infection of mice with strains of different virulence.
To examine the role of neutrophils during infection with
BJx109, HKx31 and PR8, mice were treated with mAb 1A8 prior
to and during infection with 10
5 PFU of virus. Briefly, mice were
treated with purified antibodies (0.5 mg i.p. and 0.2 mg i.n.) one
day prior to infection and every second day thereafter, as
described in Materials and Methods. Control mice received an
equivalent treatment of purified rat IgG and mice were also
treated with mAb RB6-8C5 for comparison. Mice were monitored
daily for signs of disease, changes in body weight and survival.
Effective neutrophil depletion (.90%) was confirmed by morpho-
logical analysis of blood and BAL cells (data not shown).
Uninfected mice receiving a similar regime of purified mAb
1A8, RB6-8C5 or rat IgG did not lose weight or display any
physiological abnormalities over a 10-day monitoring period (data
not shown).
Mice infected with 10
5 PFU of BJx109 and treated with either
mAb 1A8 or with control IgG did not present clinical signs of
disease or weight loss at any time-point (Fig. 4Ai), whereas BJx109-
infected mice treated with mAb RB6-8C5 lost up to 10% of their
original body weight, but recovered from infection (Fig. 4Bi). Mice
infected with HKx31 and treated with either mAb 1A8 or mAb
RB6-8C5 lost weight rapidly and all mice succumbed to disease at
day 5 post-infection (Fig. 4Aii/4Bii), whereas all IgG-treated
control animals survived infection. Compared to IgG-treated
controls, treatment of PR8-infected mice with mAb RB6-8C5 was
associated with a slight delay in weight loss in multiple experiments
(Fig. 4Aiii) whereas PR8-infected mice treated with mAb 1A8
consistently succumbed to infection 1 day earlier than IgG-treated
controls (Fig. 4Biii). Together, these data indicate that Ly6G
+
neutrophils play a beneficial role in mice following challenge with
influenza virus strains of moderate to high virulence. In contrast,
specific depletion of neutrophils using mAb 1A8 did not alter the
course of disease following infection with the avirulent BJx109
strain. Depletion of Gr-1
+ cells (using mAb RB6-8C5) was,
however, associated with significant weight loss in BJx109-infected
mice.
Effect of mAb 1A8 and mAb RB6-8C5 treatment on virus
replication in the respiratory tract following intranasal
infection
To examine the effect of neutrophils on virus replication in the
airways, mice were infected with 10
5 PFU of BJx109, HKx31 or
PR8 and treated with mAb 1A8 prior to and during infection
with each virus strain. Additional mice were treated with mAb
RB6-8C5 while control mice received an equivalent treatment
regime with purified rat IgG. Levels of infectious virus in the lung
were determined at day 5 post-infection (Fig. 5). Treatment of
BJx109-infected mice with mAb 1A8 did not alter viral load,
whereas treatment with mAb RB6-8C5 led to enhanced virus
replication and delayed clearance. Similar titres of infectious virus
were also recovered from nasal homogenates of BJx109-infected
mice treated with mAb 1A8 at this time (data not shown).
Compared to IgG-treated controls, virus titres were somewhat
elevated in the lungs of HKx31- and PR8-infected mice following
treatment with either mAb 1A8 or mAb RB6-8C5. Thus, using
mAb 1A8 we demonstrate that neutrophils can play an important
role in limiting viral replication in the lungs of mice infected with
HKx31 and PR8, but not BJx109. Depletion of Gr-1
+ cells, but
not Ly6G
high neutrophils, was associated with exacerbated
disease (Fig. 4) and virus replication (Fig. 5) in BJx109-infected
mice.
Figure 4. Effect of mAb 1A8 and mAb RB6-8C5 treatment of
mice prior to and during infection with BJx109, HKx31 or PR8.
Groups of 5 B6 mice were treated with purified (A) anti-Ly6G (1A8) or (B)
anti-Gr-1 (RB6-8C5) antibodies 24 hrs prior to virus infection and every
second day thereafter. Control mice received rat IgG (IgG). Data show
weight loss for mice infected with 10
5 PFU of (i) BJx109, (ii) HKx31 or (iii)
PR8. Mice were weighed daily and results expressed as the mean
percent weight change of each group (6 SEM), compared to original
body weight. Animals that had lost $25% of their original body weight
and/or presented with evidence of pneumonia were euthanized. Data
shown are from one experiment and are representative of two
independent experiments. The dashed line indicates days on which
the weight loss induced by treatment with (A) mAb 1A8 or (B) mAb
RB6-8C5 was statistically different to IgG-treated controls (p,0.05,
Student’s t-test).
doi:10.1371/journal.pone.0017618.g004
Neutrophils during Mild and Severe Influenza
PLoS ONE | www.plosone.org 5 March 2011 | Volume 6 | Issue 3 | e17618Neutrophils play a protective role during severe influenza
virus infections
Depletion of neutrophils was associated with a modest
enhancement in disease severity and virus replication in mice
infected with a high dose (10
5 PFU) of HKx31 and PR8 but did
not alter disease in BJx109-infected mice (Fig. 4, 5). This high
inoculum dose was used to allow avirulent BJx109 to establish
infection in the airways. Neutrophils have been proposed to
contribute to lung pathology, rather than to protection, during
PR8 infection of mice [9]. To investigate the role of neutrophils in
more detail, mice were depleted of neutrophils using mAb 1A8
and infected with a low dose (10
2 PFU) of the virulent PR8 strain
(Fig. 6A). At this lower inoculum dose, neutropenic mice lost
weight and succumbed to PR8 infection more rapidly than control
animals further highlighting the beneficial role of neutrophils
during severe influenza infections.
B6.RAG-2cc
2/2 mice are deficient in B, T, NK and NKT cells
[22] and therefore lack multiple components of innate and
adaptive immunity. In the absence of multiple mediators of
immunity, we hypothesized that the role of neutrophils during
influenza virus infection could be studied more effectively.
Compared to immunocompetent B6 animals, B6.RAG-2cc
2/2
mice are highly susceptible to infection with a low dose of HKx31
(10
2 PFU) and all mice reached the humane end-point for culling
by day 10 post-infection (data not shown). We determined
neutrophil numbers in the airways of HKx31-infected B6.RAG-
2cc
2/2 mice at day 5 and day 9 post-infection as these time-points
correlated with development of mild and severe disease,
respectively. Low numbers of neutrophils were recovered from
the airways of B6 mice at either time point (Fig. 6B). In contrast,
neutrophils numbers in BAL from B6.RAG-2cc
2/2 mice were ,5
and ,200-fold higher than B6 mice at day 5 and 9, respectively,
and by day 9,80% of BAL cells were neutrophils. BAL
neutrophils recovered from B6.RAG-2cc
2/2 infected with 10
2
PFU of HKx31 were 6–8 times higher than numbers from B6
mice infected with 10
5 PFU of PR8 (Fig. 2B). Note that similar
numbers of BAL neutrophils were recovered from the lungs of
naı ¨ve B6 and B6.RAG-2cc
2/2 mice (data not shown).
Excessive or dysregulated neutrophil recruitment has been
proposed to contribute to inflammatory lung injury [23,24] and to
the pathology of influenza virus infections [9]. Given the massive
neutrophil influx into the airways of B6.RAG-2cc
2/2 mice, we
hypothesized that under these conditions neutrophils may
contribute to pathology and disease. Therefore, immunocompe-
tent B6 mice and B6.RAG-2cc
2/2 mice were infected with 10
2
PFU of HKx31 and treated with mAb 1A8 or IgG at days (i) 21,
+1, +3, +5, +7, +9 and +11 (‘continuous treatment’), or (ii) +5, +7,
+9 and +11 relative to infection (‘late treatment’). Consistent with
our previous findings [5], commencing treatment of HKx31-
infected B6 mice with mAb 1A8 early after infection (‘continuous
treatment’) led to rapid weight loss and death (Fig. 6Ci, upper
panel) whereas ‘late treatment’ had no affect on the course of
disease (Fig. 6Cii, upper panel). In contrast, both continuous
(Fig. 6Bi, lower panel) and late treatments (Fig. 6Ci, upper panel)
of B6.RAG-2cc
2/2 mice with mAb 1A8 were associated with
accelerated weight loss and disease in HKx31-infected mice.
Together, these data indicate that the massive influx of neutrophils
into the airways of HKx31-infected B6.RAG-2cc
2/2 mice is not a
major factor contributing to disease severity. Rather, the large
numbers of airway neutrophils play a beneficial role in limiting
disease severity and delaying mortality.
Discussion
The current study contributes a number of important insights to
our understanding regarding the role of neutrophils during
influenza infection of mice. With one exception [5], previous
studies have used mAb RB6-8C5 to address the role of neutrophils
in the mouse model of influenza infection [3,4,8]. We have
compared outcomes following treatment of mice with mAb 1A8
(anti-Ly6G, specific for neutrophils) or mAb RB6-8C5 (anti-
Ly6G/C or anti-Gr-1, expressed by a range of additional
leukocyte subsets) and report that depletion of Ly6G
+ versus Gr-
1
+ cells in mice can be associated with different outcomes with
respect to virus replication and disease. Moreover, our studies
define the role of neutrophils following infection of mice with virus
strains that are known to induce mild, intermediate or severe
disease in mice. Finally, we have used virus-infected immunode-
ficient mice and mAb 1A8 to demonstrate that under conditions of
excessive recruitment to the airways, neutrophils still play a
protective rather than a pathological role.
Strain PR8 is highly adapted to growth in mouse lung and
induces interstitial pneumonia [25,26], similar to that observed in
human cases of viral pneumonia. Multiple factors have been
proposed to contribute to the virulence of PR8 including its high
growth capacity, a function of the internal genes that led to its use in
generationofhigh-yieldingreassortantstrainswith vaccine potential
[27]. BJx109, HKx31 and PR8 viruses share internal components
derived from the PR8 strain but differ markedly in their ability to
induce disease following intranasal inoculation of mice (Fig. 1), a
finding attributed to the particular HA and/or NA glycoproteins of
each virus strain. The differential ability of BJx109, HKx31 and
PR8 to replicate and induce disease in mice (Fig. 1), recruit
neutrophils to the upper and lower airways (Fig. 2) and the
particular role that neutrophils play in controlling replication and
disease (Fig. 4, 5) can be linked to the expression of distinct HA and
NA glycoproteins by each of the virus strains used.
BJx109 replicates poorly and does not induce weight loss or
disease in mice (Fig. 1) and the HA of BJx109 is highly
glycosylated, rendering it sensitive to destruction by components
of the innate immune system, including collectins [28,29] and
airway macrophages [30,31]. In previous studies we have
demonstrated that when specific components of innate immunity
are depleted (e.g. airway macrophages) [16] or blocked (e.g. by
intranasal treatment of mice with mannan to block lectin-mediated
Figure 5. Virus replication in neutropenic and control mice
following infection with BJx109, HKx31 and PR8. Groups of 5 B6
mice received i.n. and i.p. treatments with purified anti-Ly6G (1A8,
striped bars) 24 hrs prior to virus infection and every second day
thereafter. For comparison, virus-infected mice were also treated with
anti-Gr-1 (RB6-8C5, grey bars) antibodies and control mice with rat IgG
(IgG, black bars). Mice were infected with 10
5 PFU of BJx109, HKx31 or
PR8 and at day 5 post-infection mice were killed, lungs removed and
titres of infectious virus were determined in clarified homogenates by
standard plaque assay. Data represent mean viral titres titres 6 1 SD.
The detection limit for the assay is indicated by the dotted line. Viral
titres from treated mice (RB6-8C5 or 1A8) that were significantly higher
than those from control (IgG-treated) animals are indicated by
*=p,0.05, **=p,0.01 (Student’s t-test).
doi:10.1371/journal.pone.0017618.g005
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severe disease and death in mice. In contrast, specific depletion of
neutrophils via mAb 1A8 treatment did not enhance the virulence
of BJx109 for B6 mice, suggesting that alternative immune
defenses are sufficient to contain and clear infection. Intranasal
infection of B6.RAG or B6.RAG-2cc
2/2 mice with 10
5 PFU of
BJx109 does not induce weight loss or disease and BJx109-infected
B6.RAG-2cc
2/2 mice treated with mAb 1A8 did not show
enhanced morbidity (MT and PR, unpublished observations). Our
findings that mAb RB6-8C5, but not mAb 1A8, induced weight
loss and increased virus replication in BJx109-infected mice would
be consistent with recent findings that Gr-1 is upregulated on
airway macrophages, as well as NK cells, NKT cells, cDC and
pDC, during influenza virus infection [5]. Treatment of virus-
infected mice with mAb RB6-8C5 is therefore likely to deplete a
range of cells of the innate immune system, including airway
macrophages.
Neutrophils have been implicated in lung pathology in a
number of systems such as acute lung injury (ALI), acute
respiratory distress syndrome (ARDS), septic shock and asthma
(reviewed in [23,24]). Previous studies demonstrated that treat-
ment of PR8-infected mice with hyperimmune serum raised to
neutrophil chemoattractant MIP-2 improved lung pathology
without affecting virus replication and led to reduced morbidity
and mortality [9], consistent with a role for neutrophils in driving
the lung pathology associated with severe disease. High numbers
of neutrophils were also recruited to the lungs of mice infected
with pathogenic H1N1 and H5N1 influenza viruses [2,3], yet
depletion of Gr-1
+ cells, including neutrophils (using mAb RB6-
8C5 alone or in combination with clodronate-loaded liposomes to
deplete airway macrophages) was associated with exacerbated
growth and spread of a highly pathogenic recombinant virus
expressing the HA and NA of the 1918 pandemic virus [3].
Despite progressive accumulation of neutrophils in the airways
Figure 6. Neutrophils play a beneficial role during severe influenza infections of mice. (A) Groups of 5 B6 mice were treated with purified
anti-Ly6G (1A8) or rat IgG (IgG) antibodies 24 hrs prior to virus infection and every second day thereafter. Data show weight loss for mice infected
with 10
2 PFU of PR8. (B) Groups of 5 B6 or B6.RAG-2cc
2/2mice were infected with 10
2 PFU of HKx31 and at day 5 and 9 post-infection, mice were
killed and BAL performed. Numbers of BAL neutrophils from virus-infected mice are shown. Neutrophils were identified via differential counts and
Diff Quick staining, as described in Material and Methods. *=neutrophil numbers from B6.RAG-2cc
2/2 mice were significantly higher compared to
numbers from B6 mice (p,0.01, one-way ANOVA). (C) Immunocompetent B6 mice (upper panels) or B6.RAG-2cc
2/2mice (lower panels) were treated
with purified anti-Ly6G antibodies (1A8) (i) at days 21, +1, +3, +5, +7, +9 and +11 (Continuous treatment, left panels), or (ii) at days +5, +7, +9 and +11
(Late treatment, right panels) relative to infection with 10
2 PFU of HKx31 at day 0. Control mice received a similar treatment regime of rat IgG (IgG).
Arrows indicate the days mice were treated with mAb 1A8 or control rat IgG. Mice were weighed daily and results expressed as the mean percent
weight change of each group (6 SEM), compared to original body weight. Animals that had lost $25% of their original body weight and/or
presented with evidence of pneumonia were euthanized. Data shown are from one experiment and are representative of two independent
experiments. Dashed lines indicate days on which the weight loss induced by treatment with (A/C) mAb 1A8 was statistically different to IgG-treated
controls (p,0.05, Student’s t-test).
doi:10.1371/journal.pone.0017618.g006
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depleted mice succumbed more rapidly than controls (Fig. 4B).
Infection of immunodeficient B6.RAG-2cc
2/2 mice with a low
dose (10
2 PFU) of HKx31also induced massive neutrophil
recruitment to the airways (Fig. 6A) yet neutrophil depletion
during the later stages of infection (i.e. from day 5 onwards) did
not ameliorate disease (Fig. 6B). Thus, data presented herein
support the notion that neutrophils play a role in protection rather
than contributing to the pathology associated with severe disease.
Previous studies have used mAb RB6-8C5 to assess the role of
neutrophils during severe influenza infections whereas our studies
utilize Ly6G-specific mAb 1A8.
Incubation of human neutrophils with influenza virus has been
associated with intracellular detection of virus-specific proteins
[33,34,35], however infection was non-productive [33]. Further-
more, immunohistological localization of H5N1 viral proteins in
the cytoplasm and nucleus of human neutrophils led to the
proposal that neutrophils may act as a vehicle for viral
transportation and dissemination during virulent influenza virus
infections [34]. In the mouse model, previous studies have
demonstrated that casein or glycogen-induced peritoneal neutro-
phils did not support productive virus replication [6]. Herein, we
have compared the ability of virulent and avirulent virus strains to
infect and replicate within purified bone marrow-derived neutro-
phils from naı ¨ve B6 mice. Consistent with previous studies [33],
amplification of infectious progeny was not detected in cell
supernatants 24 hrs after exposure to BJx109, HKx31 or PR8.
Intracellular NP was not detected using flow cytometry (Fig. 3A)
and levels of viral mRNA and vRNA were low compared to
murine LA-4 epithelial cells (Fig. 3B). Of interest, levels of vRNA
were markedly higher than mRNA, consistent with previous
reports that neutrophils mediate phagocytic uptake of influenza
virus [6,36].
In conclusion, we have used antibody-mediated depletion of
Ly6G
+ cells to investigate the role of neutrophils during influenza
virus infection of mice. We demonstrate that neutrophils play a
role in limiting disease severity following infection of mice with
stains of intermediate (HKx31; H3N2) and high virulence (PR8;
H1N1) whereas they are not critical in controlling infection with
avirulent BJx109. Previous studies have suggested that over-
whelming or dysregulated neutrophil responses may contribute to
lung injury in inflammatory conditions, however the large
neutrophil influx associated with severe infections (i.e. PR8 in B6
mice or HKx31 in B6.RAG-2cc
2/2 mice) provided a beneficial
rather than a detrimental effect. In contrast to data obtained using
mAb 1A8, BJx109-infected mice treated with mAb RB6-8C5
showed enhanced disease severity and virus replication in the
airways. Together, these demonstrate that neutrophils can play
differing roles in modulating influenza disease depending on the
virulence of the particular strain examined. Moreover, our data
confirm the limitations associated with use of mAb RB6-8C5 to
define the role of neutrophils in vivo during inflammation and
infection.
Materials and Methods
Mice and viruses
C57BL/6 (B6) mice and RAG-2 common gamma chain-
deficient mice on a B6 background (B6. RAG-2cc
2/2) were bred
and housed in specific pathogen-free conditions at the Department
of Microbiology and Immunology, University of Melbourne,
Australia. Male 6–10 week old mice were used in all experiments.
The influenza A virus strains used in this study were A/PR/8/34
(PR8, H1N1), as well as BJx109 (H3N2) and HKx31 (H3N2),
which are high-yielding reassortants of PR8 that bear the surface
glycoproteins of A/Beijing/353/89 (H3N2) and A/Aichi/2/68
(H3N2), respectively. Viruses were grown in 10-day embryonated
hen’s eggs by standard procedures and titrated on Madin-Darby
canine kidney (MDCK) cells as described [37].
Infection and treatment of mice
For total respiratory tract infection, mice were lightly anaes-
thetized with isoflurane and infected with 10
5 PFU of BJx109,
HKx31 or PR8 via the intranasal (i.n.) route in 50 ml of phosphate
buffered saline (PBS). In some experiments, mice were inoculated
with 10
2 PFU of HKx31. Mice were weighed daily and assessed
for visual signs of clinical disease including inactivity, ruffled fur,
laboured respiration and huddling behaviour. Animals that lost
$25% of their original body weight and/or displayed evidence of
pneumonia were euthanized. All procedures were conducted in
accordance with the University of Melbourne’s Animal Experi-
mentation Ethics guidelines and policies and approved by an
institutional ethics committee (ID 0911208.1 approved by
Biochemistry & Molecular Biology, Dental Science, Medicine
(RMH), and Microbiology & Immunology committee). At various
times after infection, mice were euthanized and the lungs and
nasal tissues were removed, homogenised in PBS and clarified by
centrifugation. Titres of infectious virus in tissue homogenates
were determined by standard plaque assay on MDCK cells in the
presence of trypsin.
For the depletion of Ly6G
high neutrophils or Gr-1
+ leukocytes in
vivo, mice were treated with purified anti-Gr-1 (Ly6G and Ly6C,
RB6-8C5) or anti-Ly6G rat mAb (1A8, a gift from Prof. Thomas
Malek, Dept. Microbiology and Immunology, University of
Miami, Florida, USA), respectively. A combination of intraperi-
toneal (i.p.; 0.5 mg in 0.2 ml) and intranasal (i.n.; 0.2 mg in
0.05 ml) routes were used to obtain .90% depletion of
neutrophils in the blood as well as .90% depletion in the airways
of influenza virus-infected mice, as previously described [4,5].
Mice were treated 24 hrs prior to infection and every 48 hrs
thereafter, unless otherwise stated. Control animals received a
similar dose of purified whole rat IgG (Jackson Laboratories,
USA). Depletion of neutrophils in the blood (.95% compared to
IgG-treated control mice) and airways (.80% compared to IgG-
treated controls) was confirmed by differential leukocyte counts
(data not shown).
Recovery of leukocytes from mice
Bronchoalveolar lavage (BAL) cells and nasal tissue cells (nasal
cavity and nasal turbinates) were obtained as described [4]. To
obtain single cell suspensions, nasal tissues were finely minced with
scissors, incubated for 30 minutes at 37uC with 2 mg/mL
Collagenase A (Roche Diagnostics, Germany) and passed through
a wire mesh. Samples were treated with Tris-NH4Cl (0.14 M
NH4Cl in 17 mM Tris, adjusted to pH 7.2) to lyse erythrocytes
and washed in RPMI 1640 medium supplemented with 10% FCS
(RF10). Cell numbers and cell viability were assessed via trypan
blue exclusion using a hemocytometer.
Differential leukocyte counts and flow cytometry
BAL and blood samples were analyzed by differential leukocyte
counts as described [4]. For flow cytometry analysis, single cell
suspensions prepared from BAL, lung and nasal tissues were
incubated on ice for 20 minutes with supernatants from
hybridoma 2.4G2 to block Fc receptors and then stained with
appropriate combinations of fluorescein isothiocyanate (FITC),
phycoerythrin (PE), allophycocyanin (APC) or biotinylated
monoclonal antibodies to Gr-1 (RB6-8C5) or CD45.2 (104).
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10 mg/ml) to each sample and cells were analysed on a FACS
Calibur flow cytometer. A minimum of 50,000 PI
2 cells were
collected. Leukocyte populations were sorted using a MoFlo cell
sorter (DakoCytomation, Denmark).
Detection of neutrophil chemoattractants in BAL
supernatants
BAL supernatants from naı ¨ve and virus-infected mice were
assessed for levels of MIP-1a (CCL3), MIP-2 (CXCL2) and KC
(CXCL1) using ELISA kits (R&D Systems, USA) according to
manufacturer’s instructions. Chemoattractant concentrations were
calculated from a standard curve and expressed as pg/mL.
Purification of neutrophils from bone marrow
Mature neutrophils were purified from bone marrow of B6 mice
by Dr. Ben Croker, Walter and Eliza Hall Institute of Medical
Research, Melbourne, Australia, using a method adapted from
Boxio et al [38]. Briefly, bone marrow cells were separated using a
3-layered gradient of 1.110 g/ml, 1.090 g/ml, and 1.083 g/ml
Percoll PLUS (Amersham, Sweden). Percoll layers were prepared
by diluting 100% Percoll (9 parts Percoll+1 part 106 HBSS,
pH 7.1) with HBSS. After centrifugation (1500 g, 30 mins, no
brake), neutrophils were collected from the 1.110 g/ml to
1.090 g/ml interface. Contaminants were further enriched via
incubation with biotinylated anti-B220 and anti-Ter119 antibod-
ies, followed by the addition of streptavidin-labelled Dynabeads
(Invitrogen, USA). Cells were counted by trypan blue exclusion
and purity was assessed to be .99% by differential counts of
cytospin preparations stained with Diff-Quick (Amber Scientific,
Australia).
Infection of murine cells by influenza virus and detection
of viral antigen using flow cytometry
For the detection of intracellular viral nucleoprotein (NP), 10
6
purified mature bone-marrow neutrophils (prepared as described
above) or LA-4 cells (murine airway epithelial cell line) were mock-
infected with media alone or infected with 10
7 PFU of influenza
virus in suspension for 1 hr at 37uC. Cells were then washed and
incubated for 8 hrs at 37uC. Cells were fixed with 80% (v/v)
acetone and incubated with mAb MP3.10G2.IC7, specific for the
nucleoprotein (NP) of type A influenza viruses (from WHO
Collaborating Centre for Reference and Research on Influenza),
followed by FITC-conjugated sheep anti-mouse Ig (Silenus,
Australia) in the presence of 0.2% saponin. Levels of intracellular
viral NP was determined using flow cytometry.
Quantitative RT-PCR (qRT-PCR) for influenza virus genes
10
6 purified mature bone-marrow neutrophils (prepared as
described above) and LA-4 cells were incubated with 10
7 PFU of
influenza virus in suspension for 1 hr at 37uC. Cells were then
washed and incubated for 8 hrs at 37uC. RNA was extracted from
the cell pellet using the RNeasy Mini Kit (Qiagen, USA) according
to manufacturer’s instructions and stored at 270uC. Levels of viral
RNA (vRNA) and viral messenger RNA (mRNA) of polymerase A
subunit (PA) and matrix (M) genes were determined via qRT-PCR
using TaqMan chemistry. Reactions contained 5 ml of RNA
template, 16 TaqMan one-step RT-PCR master mix (Applied
Biosystems, USA), 16 MultiScribe and RNase inhibitor mix
(Applied Biosystems) and 0.5 mM of each primer and probe in a
total reaction volume of 25 ml. For the detection of negative sense
vRNA, the forward primer was added to the reaction mixture first,
and the reverse transcriptase reaction was incubated at 50uC for
30 mins. The reverse primer was then added and quantitative
PCR was performed using the following conditions; 94uC for
15 mins, followed by 40 cycles of denaturation/amplification
(95uC for 30 secs, 60uC for 60 secs). For the detection of positive
sense viral mRNA, the reverse primer was added to the reaction
mixture first followed by the forward primer. A standard curve was
created using serial dilutions of plasmids containing the target gene
and the detection limit was 1 pg/ml, the lowest standard included
in the assay. RNA content in test samples were expressed as pg/
ml. The following primer and probe sequences were used: M;
Forward: ATG CAA CGG TTC AAG TGA TCC T, Reverse:
GTC AAG TGC AAG ATC CCA ATG AT, Probe: CAC TAT
TGC CGC AAA T (VIC), and PA; Forward: ACA AGG CAT
GCG AAC TGA CA, Reverse: TGG AGC CAC ATC TTC
TCC AA, Probe: ATT CAA GCT GGA TAG AGC (VIC).
Statistical analysis
For the comparison of two sets of values, a Student’s t test (two-
tailed, two-sample equal variance) was used. When comparing
three or more sets of values, a one-way ANOVA test was applied
followed by the Tukey post-test. A p value of #0.05 was
considered statistically significant for all tests utilized.
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